Literature DB >> 21539842

Mediators of oligodendrocyte differentiation during remyelination.

Jigisha R Patel1, Robyn S Klein.   

Abstract

Myelin, a dielectric sheath that wraps large axons in the central and peripheral nervous systems, is essential for proper conductance of axon potentials. In multiple sclerosis (MS), autoimmune-mediated damage to myelin within the central nervous system (CNS) leads to progressive disability primarily due to limited endogenous repair of demyelination with associated axonal pathology. While treatments are available to limit demyelination, no treatments are available to promote myelin repair. Studies examining the molecular mechanisms that promote remyelination are therefore essential for identifying therapeutic targets to promote myelin repair and thereby limit disability in MS. Here, we present our current understanding of the critical extracellular and intracellular pathways that regulate the remyelinating capabilities of oligodendrocyte precursor cells (OPCs) within the adult CNS.
Copyright © 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21539842      PMCID: PMC3158966          DOI: 10.1016/j.febslet.2011.04.037

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  110 in total

1.  The chemokine SDF1a coordinates tissue migration through the spatially restricted activation of Cxcr7 and Cxcr4b.

Authors:  Guillaume Valentin; Petra Haas; Darren Gilmour
Journal:  Curr Biol       Date:  2007-06-19       Impact factor: 10.834

2.  Insulin-like growth factor (IGF) signaling through type 1 IGF receptor plays an important role in remyelination.

Authors:  Jeffrey L Mason; Shouhong Xuan; Ioannis Dragatsis; Argiris Efstratiadis; James E Goldman
Journal:  J Neurosci       Date:  2003-08-20       Impact factor: 6.167

3.  Notch receptor activation inhibits oligodendrocyte differentiation.

Authors:  S Wang; A D Sdrulla; G diSibio; G Bush; D Nofziger; C Hicks; G Weinmaster; B A Barres
Journal:  Neuron       Date:  1998-07       Impact factor: 17.173

4.  Chronic interleukin-1beta expression in mouse brain leads to leukocyte infiltration and neutrophil-independent blood brain barrier permeability without overt neurodegeneration.

Authors:  Solomon S Shaftel; Thaddeus J Carlson; John A Olschowka; Stephanos Kyrkanides; Sarah B Matousek; M Kerry O'Banion
Journal:  J Neurosci       Date:  2007-08-29       Impact factor: 6.167

5.  Remyelination protects axons from demyelination-associated axon degeneration.

Authors:  K A Irvine; W F Blakemore
Journal:  Brain       Date:  2008-05-18       Impact factor: 13.501

6.  The type I interleukin-1 receptor acts in series with tumor necrosis factor (TNF) to induce arthritis in TNF-transgenic mice.

Authors:  L Probert; D Plows; G Kontogeorgos; G Kollias
Journal:  Eur J Immunol       Date:  1995-06       Impact factor: 5.532

7.  Multiple sclerosis: re-expression of a developmental pathway that restricts oligodendrocyte maturation.

Authors:  Gareth R John; Sai Latha Shankar; Bridget Shafit-Zagardo; Aldo Massimi; Sunhee C Lee; Cedric S Raine; Celia F Brosnan
Journal:  Nat Med       Date:  2002-09-23       Impact factor: 53.440

8.  LINGO-1 antagonist promotes spinal cord remyelination and axonal integrity in MOG-induced experimental autoimmune encephalomyelitis.

Authors:  Sha Mi; Bing Hu; Kyungmin Hahm; Yi Luo; Edward Sai Kam Hui; Qiuju Yuan; Wai Man Wong; Li Wang; Huanxing Su; Tak-Ho Chu; Jiasong Guo; Wenming Zhang; Kwok-Fai So; Blake Pepinsky; Zhaohui Shao; Christilyn Graff; Ellen Garber; Vincent Jung; Ed Xuekui Wu; Wutian Wu
Journal:  Nat Med       Date:  2007-09-30       Impact factor: 53.440

9.  Disease-responsive neural precursor cells are present in multiple sclerosis lesions.

Authors:  Heidi Snethen; Seth Love; Neil Scolding
Journal:  Regen Med       Date:  2008-11       Impact factor: 3.806

10.  PDGF and FGF2 regulate oligodendrocyte progenitor responses to demyelination.

Authors:  Emma E Frost; Joseph A Nielsen; Tuan Q Le; Regina C Armstrong
Journal:  J Neurobiol       Date:  2003-02-15
View more
  29 in total

1.  Oligodendrocytes Death Induced Sensorimotor and Cognitive Deficit in N-nitro-L-arginine methyl Rat Model of Pre-eclampsia.

Authors:  Olayemi K Ijomone; Philemon Dauda Shallie; Thajasvarie Naicker
Journal:  Neurochem Res       Date:  2020-01-25       Impact factor: 3.996

2.  TGFα preserves oligodendrocyte lineage cells and improves white matter integrity after cerebral ischemia.

Authors:  Xuejiao Dai; Jie Chen; Fei Xu; Jingyan Zhao; Wei Cai; Zeyu Sun; T Kevin Hitchens; Lesley M Foley; Rehana K Leak; Jun Chen; Xiaoming Hu
Journal:  J Cereb Blood Flow Metab       Date:  2019-03-05       Impact factor: 6.200

3.  Generation of demyelination models by targeted ablation of oligodendrocytes in the zebrafish CNS.

Authors:  Ah-Young Chung; Pan-Soo Kim; Suhyun Kim; Eunmi Kim; Dohyun Kim; Inyoung Jeong; Hwan-Ki Kim; Jae-Ho Ryu; Cheol-Hee Kim; June Choi; Jin-Ho Seo; Hae-Chul Park
Journal:  Mol Cells       Date:  2013-06-25       Impact factor: 5.034

4.  Epidural Spinal Cord Stimulation Promotes Motor Functional Recovery by Enhancing Oligodendrocyte Survival and Differentiation and by Protecting Myelin after Spinal Cord Injury in Rats.

Authors:  Gang Li; Zhong-Kai Fan; Guang-Fei Gu; Zhi-Qiang Jia; Qiang-Qiang Zhang; Jun-Yu Dai; Shi-Sheng He
Journal:  Neurosci Bull       Date:  2019-11-16       Impact factor: 5.203

5.  LINGO-1-Fc-Transduced Neural Stem Cells Are Effective Therapy for Chronic Stage Experimental Autoimmune Encephalomyelitis.

Authors:  Xing Li; Yuan Zhang; Yaping Yan; Bogoljub Ciric; Cun-Gen Ma; Jeannie Chin; Mark Curtis; Abdolmohamad Rostami; Guang-Xian Zhang
Journal:  Mol Neurobiol       Date:  2016-06-25       Impact factor: 5.590

6.  A regenerative approach to the treatment of multiple sclerosis.

Authors:  Brian R Lawson; Peter G Schultz; Luke L Lairson; Vishal A Deshmukh; Virginie Tardif; Costas A Lyssiotis; Chelsea C Green; Bilal Kerman; Hyung Joon Kim; Krishnan Padmanabhan; Jonathan G Swoboda; Insha Ahmad; Toru Kondo; Fred H Gage; Argyrios N Theofilopoulos
Journal:  Nature       Date:  2013-10-09       Impact factor: 49.962

7.  Different roles of CXCR1 and CXCR2 in HTLV-1 carriers and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients.

Authors:  Taraneh Rajaei; Hamid Farajifard; Seyed Abdolrahim Rezaee; Mahmoud Reza Azarpazhooh; Mahmoud Mahmoudi; Narges Valizadeh; Houshang Rafatpanah
Journal:  Med Microbiol Immunol       Date:  2018-10-20       Impact factor: 3.402

Review 8.  Myelin damage due to local quantitative abnormalities in normal prion levels: evidence from subacute combined degeneration and multiple sclerosis.

Authors:  Giuseppe Scalabrino; Daniela Veber
Journal:  J Neurol       Date:  2013-10-20       Impact factor: 4.849

9.  Immunity and inflammation in neurodegenerative diseases.

Authors:  Giuseppe Cappellano; Miryam Carecchio; Thomas Fleetwood; Luca Magistrelli; Roberto Cantello; Umberto Dianzani; Cristoforo Comi
Journal:  Am J Neurodegener Dis       Date:  2013-06-21

10.  α-Synuclein impairs oligodendrocyte progenitor maturation in multiple system atrophy.

Authors:  Verena E L May; Benjamin Ettle; Anne-Maria Poehler; Silke Nuber; Kiren Ubhi; Edward Rockenstein; Beate Winner; Michael Wegner; Eliezer Masliah; Jürgen Winkler
Journal:  Neurobiol Aging       Date:  2014-03-04       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.